AUG 17, 2019 08:44 AM PDT

New method to stop metastasis in lymph nodes

Research reported recently in ACS Nano explains a new method of targeting metastases in lymph nodes as a means of preventing the spread of cancers. The approach could provide novel treatment methods for patients vulnerable to metastasis, the process during which cancer cells separate from the primary tumor to form tumors at other sites. Metastasis is leading cause of cancer deaths.

This strategy targets lymph nodes because metastatic cancer usually spreads first to these glands through small vessels called lymphatics, which carry immune cells and fluid. While most conventional treatment options utilize biopsies of the lymph nodes to see if metastasis has occurred, taking a biopsy is an invasive procedure that can cause pain and infection. Instead of biopsies, the method developed by researchers Hong-Jun Li, Jin-Zhi Du and colleagues uses a nanoparticle delivery tool, called iCluster.

iCluster is already used as a nanoparticle delivery tool to bring chemotherapies directly to tumors, but by injecting iCluster combined with a red dye into mice with tumors, the researchers figured out that iCluster is also capable of entering a tumor and passing through the lymphatics. Using fluorescent imaging, the scientists saw that this mechanism provides a channel to target the lymph nodes directly and potentially treat metastases.

The study concluded that 40% of the treated mice treated with iCluster were still alive 110 days following the removal of the tumor; in comparison, those mice that did not receive treatment from iCluster before the removal of tumors all died from metastases within 51 days of surgery. Additionally, while the iCluster-treated mice lived longer, they also were seen to have far fewer tumors than untreated mice.

The authors explain their findings, stating, “Here, we uncovered that improved perfusion in a primary tumor facilitates nanoparticle translocation to lymph nodes for inhibiting tumor metastasis. On the basis of our finding that an iCluster platform…markedly improved particle perfusion in the interstitium of the primary tumor, we further revealed in the current study that such tumor-specific size transition promoted particle intravasation into tumor lymphatics and migration into lymph nodes.”

Sources: Science Daily, ACS Nano

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 22, 2020
Cancer
JAN 22, 2020
When the numbers don't match: inaccuracy in late state breast cancer survival estimates
According to the World Health Organization, about 2.1 million women are diagnosed with breast cancer annually. It is the cancer that most affects women and...
JAN 22, 2020
Cancer
JAN 22, 2020
The cancerous fear of circular extrachromosomal DNA
New research published in Nature suggests that ring-shaped extrachromosomal DNA (ecDNA) is particularly abundant in tumor cells and plays a malicious role ...
JAN 22, 2020
Immunology
JAN 22, 2020
Protecting Killer Immune Cells from Themselves
Destroying human cells compromised by viruses and cancer is the name of the game for so-called “killer” cells of the immune system. They employ...
JAN 22, 2020
Health & Medicine
JAN 22, 2020
Study finds association between hair products and breast cancer risk
For many women, hair color and style are significant components of their identity. However, troubling information from a new study about the use of hair dy...
JAN 22, 2020
Cancer
JAN 22, 2020
Should we be concerned about talc powder and ovarian cancer?
After the outcry against baby powder and concerns regarding its link to ovarian cancer, still, no investigations have clearly linked the product to the dis...
JAN 22, 2020
Cell & Molecular Biology
JAN 22, 2020
Repurposing Existing Drugs to Treat Cancer
Drugs have to be rigorously tested before they can be offered to patients, so it can be much easier to find more than one application for a medication....
Loading Comments...